AIMS/HYPOTHESIS: It is thought that the voltage-dependent potassium channel subunit Kv2.1 (Kv2.1) regulates insulin secretion by controlling beta cell electrical excitability. However, this role of Kv2.1 in human insulin secretion has been questioned. Interestingly, Kv2.1 can also regulate exocytosis through direct interaction of its C-terminus with the soluble NSF attachment receptor (SNARE) protein, syntaxin 1A. We hypothesised that this interaction mediates insulin secretion independently of Kv2.1 electrical function. METHODS: Wild-type Kv2.1 or mutants lacking electrical function and syntaxin 1A binding were studied in rodent and human beta cells, and in INS-1 cells. Small intracellular fragments of the channel were used to disrupt native Kv2.1-syntaxin 1A complexes. Single-cell exocytosis and ion channel currents were monitored by patch-clamp electrophysiology. Interaction between Kv2.1, syntaxin 1A and other SNARE proteins was probed by immunoprecipitation. Whole-islet Ca(2+)-responses were monitored by ratiometric Fura red fluorescence and insulin secretion was measured. RESULTS: Upregulation of Kv2.1 directly augmented beta cell exocytosis. This happened independently of channel electrical function, but was dependent on the Kv2.1 C-terminal syntaxin 1A-binding domain. Intracellular fragments of the Kv2.1 C-terminus disrupted native Kv2.1-syntaxin 1A interaction and impaired glucose-stimulated insulin secretion. This was not due to altered ion channel activity or impaired Ca(2+)-responses to glucose, but to reduced SNARE complex formation and Ca(2+)-dependent exocytosis. CONCLUSIONS/ INTERPRETATION: Direct interaction between syntaxin 1A and the Kv2.1 C-terminus is required for efficient insulin exocytosis and glucose-stimulated insulin secretion. This demonstrates that native Kv2.1-syntaxin 1A interaction plays a key role in human insulin secretion, which is separate from the channel's electrical function.
AIMS/HYPOTHESIS: It is thought that the voltage-dependent potassium channel subunit Kv2.1 (Kv2.1) regulates insulin secretion by controlling beta cell electrical excitability. However, this role of Kv2.1 in humaninsulin secretion has been questioned. Interestingly, Kv2.1 can also regulate exocytosis through direct interaction of its C-terminus with the soluble NSF attachment receptor (SNARE) protein, syntaxin 1A. We hypothesised that this interaction mediates insulin secretion independently of Kv2.1 electrical function. METHODS: Wild-type Kv2.1 or mutants lacking electrical function and syntaxin 1A binding were studied in rodent and human beta cells, and in INS-1 cells. Small intracellular fragments of the channel were used to disrupt native Kv2.1-syntaxin 1A complexes. Single-cell exocytosis and ion channel currents were monitored by patch-clamp electrophysiology. Interaction between Kv2.1, syntaxin 1A and other SNARE proteins was probed by immunoprecipitation. Whole-islet Ca(2+)-responses were monitored by ratiometric Fura red fluorescence and insulin secretion was measured. RESULTS: Upregulation of Kv2.1 directly augmented beta cell exocytosis. This happened independently of channel electrical function, but was dependent on the Kv2.1 C-terminal syntaxin 1A-binding domain. Intracellular fragments of the Kv2.1 C-terminus disrupted native Kv2.1-syntaxin 1A interaction and impaired glucose-stimulated insulin secretion. This was not due to altered ion channel activity or impaired Ca(2+)-responses to glucose, but to reduced SNARE complex formation and Ca(2+)-dependent exocytosis. CONCLUSIONS/ INTERPRETATION: Direct interaction between syntaxin 1A and the Kv2.1 C-terminus is required for efficient insulin exocytosis and glucose-stimulated insulin secretion. This demonstrates that native Kv2.1-syntaxin 1A interaction plays a key role in humaninsulin secretion, which is separate from the channel's electrical function.
Authors: S N Yang; O Larsson; R Bränström; A M Bertorello; B Leibiger; I B Leibiger; T Moede; M Köhler; B Meister; P O Berggren Journal: Proc Natl Acad Sci U S A Date: 1999-08-31 Impact factor: 11.205
Authors: Takahiro Kanno; Xiasong Ma; Sebastian Barg; Lena Eliasson; Juris Galvanovskis; Sven Göpel; Max Larsson; Erik Renström; Patrik Rorsman Journal: Methods Date: 2004-08 Impact factor: 3.608
Authors: James Herrington; Manuel Sanchez; Denize Wunderler; Lizhen Yan; Randal M Bugianesi; Ivy E Dick; Sam A Clark; Richard M Brochu; Birgit T Priest; Martin G Kohler; Owen B McManus Journal: J Physiol Date: 2005-06-02 Impact factor: 5.182
Authors: David A Jacobson; Andrey Kuznetsov; James P Lopez; Shera Kash; Carina E Ammälä; Louis H Philipson Journal: Cell Metab Date: 2007-09 Impact factor: 27.287
Authors: Natalia A Tamarina; Andrey Kuznetsov; Leonid E Fridlyand; Louis H Philipson Journal: Am J Physiol Endocrinol Metab Date: 2005-07-12 Impact factor: 4.310
Authors: Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Quan Zhang; Jovita Karanauskaite; Chris Partridge; Paul R Johnson; Patrik Rorsman Journal: Diabetes Date: 2008-04-04 Impact factor: 9.461
Authors: Mette V Jensen; Jonathan M Haldeman; Hengtao Zhang; Danhong Lu; Mark O Huising; Wylie W Vale; Hans E Hohmeier; Paul Rosenberg; Christopher B Newgard Journal: J Biol Chem Date: 2013-06-20 Impact factor: 5.157
Authors: Chao Ling; Matthew Pease; Lingling Shi; Vasu Punj; Mark S Shiroishi; Deborah Commins; Daniel J Weisenberger; Kai Wang; Gabriel Zada Journal: PLoS One Date: 2014-04-29 Impact factor: 3.240
Authors: Meghan C McCord; Paul H Kullmann; Kai He; Karen A Hartnett; John P Horn; Ilana Lotan; Elias Aizenman Journal: J Physiol Date: 2014-06-13 Impact factor: 5.182
Authors: Jianyang Fu; Xiaoqing Dai; Gregory Plummer; Kunimasa Suzuki; Austin Bautista; John M Githaka; Laura Senior; Mette Jensen; Dafna Greitzer-Antes; Jocelyn E Manning Fox; Herbert Y Gaisano; Christopher B Newgard; Nicolas Touret; Patrick E MacDonald Journal: Diabetes Date: 2017-06-12 Impact factor: 9.461